This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing asenapine for Bipolarity type I.
BipolarityDrugOver 18 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Asenapine may be useful for adults experiencing bipolarity.
What would participation involve?
Participants may receive Asenapine, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Bulgaria, in Croatia, and in India.
Who is it mainly for?
This study appears to be mainly for adults with bipolarity.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateDecember 2011
Recruitment status
Completed
Enrollment listed in the registry
561
Sponsor
Forest Laboratories
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Bulgaria, Croatia, ...
Age range
Over 18 Years
Official registry ID
NCT01396291
Official title
A Double-Blind, Placebo-Controlled Trial of Asenapine in the Prevention of Recurrence of a Mood Episode After Stabilization of an Acute Manic/Mixed Episode in Subjects With Bipolar 1 Disorder (Phase 3B, Protocol P06384)
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT01396291. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Bulgaria · 7 sites
Forest Investigative Site 3105
Pleven, Pleven
Site status: Not listed — confirm with the team
Forest Investigative Site 3104
Sofia, Sofia-Grad
Site status: Not listed — confirm with the team
Forest Investigative Site 3100
Sofia, Sofia-Grad
Site status: Not listed — confirm with the team
Forest Investigative Site 3106
Sofia, Sofia-Grad
Site status: Not listed — confirm with the team
Forest Investigative Site 3101
Varna, Varna
Site status: Not listed — confirm with the team
Forest Investigative Site 3102
Burgas
Site status: Not listed — confirm with the team
Forest Investigative Site 3103
Varna
Site status: Not listed — confirm with the team
Croatia · 4 sites
Forest Investigative Site 3153
Zagreb, City of Zagreb
Site status: Not listed — confirm with the team
Forest Investigative Site 3154
Zagreb, City of Zagreb
Site status: Not listed — confirm with the team
Forest Investigative Site 3152
Zagreb, City of Zagreb
Site status: Not listed — confirm with the team
Forest Investigative Site 3156
Rijeka, Rijeka
Site status: Not listed — confirm with the team
India · 6 sites
Forest Investigative Site 3308
Nashik, Andhra Pradesh
Site status: Not listed — confirm with the team
Forest Investigative Site 3306
Ahmedabad, Gujarat
Site status: Not listed — confirm with the team
Forest Investigative Site 3305
Ahmedabad, Gujaratc
Site status: Not listed — confirm with the team
Forest Investigative Site 3307
Nashik, Madhya Pradesh
Site status: Not listed — confirm with the team
Forest Investigative Site 3302
Kanpur, Uttar Pradesh
Site status: Not listed — confirm with the team
Forest Investigative Site 3303
Hyderabad
Site status: Not listed — confirm with the team
Philippines · 4 sites
Forest Investigative Site 3353
Cebu, Cebu
Site status: Not listed — confirm with the team
Forest Investigative Site 3352
Iloilo City, Iloilo
Site status: Not listed — confirm with the team
Forest Investigative Site 3356
Mandaluyong, Mandaluyong
Site status: Not listed — confirm with the team
Forest Investigative Site 3351
Manila, National Capital Region
Site status: Not listed — confirm with the team
Romania · 7 sites
Forest Investigative Site 3128
Bucharest, Bucharest
Site status: Not listed — confirm with the team
Forest Investigative Site 3129
Bucharest, Bucharest
Site status: Not listed — confirm with the team
Forest Investigative Site 3130
Bucharest, Bucharest
Site status: Not listed — confirm with the team
Forest Investigative Site 3131
Targoviste, Dâmbovița County
Site status: Not listed — confirm with the team
Forest Investigative Site 3125
Iași, Iaşi
Site status: Not listed — confirm with the team
Forest Investigative Site 3126
Targu Mureş, Mureș County
Site status: Not listed — confirm with the team
Forest Investigative Site 3127
Arad
Site status: Not listed — confirm with the team
Russia · 5 sites
Forest Investigative Site 3205
Kazan', Kazan
Site status: Not listed — confirm with the team
Forest Investigative Site 3202
Moscow, Moscow
Site status: Not listed — confirm with the team
Forest Investigative Site 3200
Moscow, Moscow
Site status: Not listed — confirm with the team
Forest Investigative Site 3201
Saint Petersburg, Sankt-Peterburg
Site status: Not listed — confirm with the team
Forest Investigative Site 3204
Smolensk, Smolensk Oblast
Site status: Not listed — confirm with the team
Serbia · 7 sites
Forest Investigative Site 3177
Belgrade, Belgrade
Site status: Not listed — confirm with the team
Forest Investigative Site 3176
Belgrade, Beograd
Site status: Not listed — confirm with the team
Forest Investigative Site 3179
Belgrade, Beograd
Site status: Not listed — confirm with the team
Forest Investigative Site 3182
Belgrade, Beograd
Site status: Not listed — confirm with the team
Forest Investigative Site 3178
Kragujevac, Kragujevac
Site status: Not listed — confirm with the team
Forest Investigative Site 3180
Kragujevac, Kragujevac
Site status: Not listed — confirm with the team
Forest Investigative Site 3182
Novi Kneževac, Vojvodina
Site status: Not listed — confirm with the team
Türkiye · 3 sites
Forest Investigative Site 3252
Korucuk, Adapazari
Site status: Not listed — confirm with the team
Forest Investigative Site 3255
Ankara, Ankara
Site status: Not listed — confirm with the team
Forest Investigative Site 3257
Diyarbakır, Diyarbakır
Site status: Not listed — confirm with the team
Ukraine · 7 sites
Forest Investigative Site 3230
Chernihiv, Chernihiv Oblast
Site status: Not listed — confirm with the team
Forest Investigative Site 3228
Kharkiv, Kharkiv Oblast
Site status: Not listed — confirm with the team
Forest Investigative Site 3226
Kyiv, Kyiv Oblast
Site status: Not listed — confirm with the team
Forest Investigative Site 3229
Kyiv, Kyiv Oblast
Site status: Not listed — confirm with the team
Forest Investigative Site 3227
Luhansk, Luhansk Oblast
Site status: Not listed — confirm with the team
Forest Investigative Site 3233
Kherson
Site status: Not listed — confirm with the team
Forest Investigative Site 3232
Lviv
Site status: Not listed — confirm with the team
United States · 30 sites
Forest Investigative Site 3017
Anaheim, California
Site status: Not listed — confirm with the team
Forest Investigative Site 3019
Chino, California
Site status: Not listed — confirm with the team
Forest Investigative Site 3001
Escondido, California
Site status: Not listed — confirm with the team
Forest Investigative Site 3004
National City, California
Site status: Not listed — confirm with the team
Forest Investigative Site 3006
Oakland, California
Site status: Not listed — confirm with the team
Forest Investigative Site 3003
Orange, California
Site status: Not listed — confirm with the team
Forest Investigative Site 3007
Torrance, California
Site status: Not listed — confirm with the team
Forest Investigative Site 3042
Colorado Springs, Colorado
Site status: Not listed — confirm with the team
Forest Investigative Site 3012
Jacksonville, Florida
Site status: Not listed — confirm with the team
Forest Investigative Site 3040
Kissimmee, Florida
Site status: Not listed — confirm with the team
Forest Investigative Site 3031
Leesburg, Florida
Site status: Not listed — confirm with the team
Forest Investigative Site 3015
Miami, Florida
Site status: Not listed — confirm with the team
Forest Investigative Site 3010
Tampa, Florida
Site status: Not listed — confirm with the team
Forest Investigative Site 3039
Atlanta, Georgia
Site status: Not listed — confirm with the team
Forest Investigative Site 3032
Chicago, Illinois
Site status: Not listed — confirm with the team
Forest Investigative Site 3029
Schaumburg, Illinois
Site status: Not listed — confirm with the team
Forest Investigative Site 3021
Witchita, Kansas
Site status: Not listed — confirm with the team
Forest Investigative Site 3014
Gladstone, Missouri
Site status: Not listed — confirm with the team
Forest Investigative Site 3002
Albuquerque, New Mexico
Site status: Not listed — confirm with the team
Forest Investigative Site 3024
Elmsford, New York
Site status: Not listed — confirm with the team
Forest Investigative Site 3037
Avon Lake, Ohio
Site status: Not listed — confirm with the team
Forest Investigative Site 3041
Cincinnati, Ohio
Site status: Not listed — confirm with the team
Forest Investigative Site 3023
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
Forest Investigative Site 3035
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
Forest Investigative Site 3033
Memphis, Tennessee
Site status: Not listed — confirm with the team
Forest Investigative Site 3009
Houston, Texas
Site status: Not listed — confirm with the team
Forest Investigative Site 3020
Houston, Texas
Site status: Not listed — confirm with the team
Forest Investigative Site 3036
Irving, Texas
Site status: Not listed — confirm with the team
Forest Investigative Site 3027
Plano, Texas
Site status: Not listed — confirm with the team
Forest Investigative Site 3000
Wichita Falls, Texas
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving asenapine, placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with bipolarity; age range: Over 18 Years. The criteria appear strict, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Forest Laboratories, which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
